Next Generation EU: A EUR 5 Billion Modernization Opportunity
The outbreak of the COVID-19 pandemic put an end to more than five years of economic growth in Spain. But the country was not alone. Due to strict containment measures,…
Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. For more than 75 years, our products have been making a difference in peoples’ lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery.
Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences.
✔Our diagnostics customers include hospitals and laboratories around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients.
✔Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.
✔As part of Life Sciences, the Particle Characterization and Counting business serves biopharma production and QC environments, as well as research functions within large biopharma companies.
Contact details:
Torre Realia
4ª Planta
Plaza de Europa 41-43
08908 L’Hospitalet de Llobregat, Barcelona
Tel. +34 935 47 36 00
Fax. +34 935 47 36 10
MADRID OFFICE
Calle de Valgrande 8
28108 Alcobendas, Madrid
Tel. +34 917 93 11 93
Fax. +34 917 93 11 90
The outbreak of the COVID-19 pandemic put an end to more than five years of economic growth in Spain. But the country was not alone. Due to strict containment measures,…
After decades of investment, Catalonia has secured its healthcare and life sciences hub status, accounting for more than half of Spain’s pharma exports and with more clinical trials than any…
Its unorthodox name reflecting a somewhat unconventional approach, mAbxience has achieved some significant milestones in its short history, including becoming the only privately-owned company in the world with less than…
Kyowa Kirin’s head of the South Europe cluster, Norberto Villarrasa, explains the Japanese company’s presence in Spain, its focus on rare diseases and onco-haematology, and comments on the challenges around…
UCB’s general manager for Iberia, Pau Ricós, comments on the Belgian company’s upcoming launches, its focus on immunology and neurology, and the importance of R&D – UCB spent around 28…
João Madeira, General Manager of Viatris Spain discusses the position of the Spanish affiliate and the challenges of a generous decentralised healthcare system. He also outlines some of Viatris’ successes…
In 2021, a hospital in Barcelona managed to get approval for the first European-developed CAR-T cell therapy. Aided by a little girl and her mother, a team of doctors at…
Boston Scientific’s Spain country coordinator, Carlos Sabrido, analyses the Spanish med-tech market, comments on the transformation of Boston Scientific – going from a medical devices to a health solutions company…
Spain is playing an important role in the production of COVID-19 vaccines with four Spanish companies involved in vaccine manufacturing projects, three of them doing fill and finish and one…
The long-time CEO of Reig Jofre, Ignasi Biosca Reig, reflects on the company’s role during the pandemic producing essential medicines and the support given by national and European authorities. He…
After five years of raising funds, the Sant Joan de Deu (SJD) Pediatric Cancer Center Barcelona, the largest monographic paediatric oncological centre in Europe will open its doors on June…
Organon’s general manager for Spain and Portugal, Juan Vera, explains the challenges of executing the spinoff from MSD in the middle of the pandemic, the reasons why his affiliate has…
See our Cookie Privacy Policy Here
